ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1-Reference-Cited by-同舟云学术

ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1

Published:2021-12-09 Issue:1 Volume:3 Page:75-89
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

Zhang Tong,Sun Linchong^ORCID,Hao Yijie,Suo Caixia,Shen Shengqi,Wei Haoran,Ma Wenhao,Zhang Pinggen,Wang Ting,Gu Xuemei,Li Shi-Ting,Chen Zhaolin,Yan Ronghui,Zhang Yi,Cai Yongping,Zhou Rongbin,Jia Weidong,Huang Fang,Gao Ping^ORCID,Zhang Huafeng^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s43018-021-00299-1.pdf

Reference68 articles.

1. Faubert, B., Solmonson, A. & DeBerardinis, R. J. Metabolic reprogramming and cancer progression. Science 368, 152–161 (2020).

2. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).

3. Pavlova, N. N. & Thompson, C. B. The emerging hallmarks of cancer metabolism. Cell Metab. 23, 27–47 (2016).

4. Castello, A., Hentze, M. W. & Preiss, T. Metabolic enzymes enjoying new partnerships as RNA-binding proteins. Trends Endocrinol. Metab. 26, 746–757 (2015).

5. Xu, D. et al. The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis. Nature 580, 530–535 (2020).

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy;Frontiers in Immunology;2024-09-09

2. Divergent iron regulatory states contribute to heterogeneity in breast cancer aggressiveness;iScience;2024-09

3. MMP9 drives ferroptosis by regulating GPX4 and iron signaling;iScience;2024-09

4. A promising new approach to cancer therapy: Manipulate ferroptosis by hijacking endogenous iron;International Journal of Pharmaceutics;2024-09

5. Ferroptosis in health and disease;Redox Biology;2024-09